The purpose of this acquisition is to provide field center support services in the birmingham, AL area to maximizeuse of data and samples amassed in cardia over more than 30 years to address new…
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N92018D00007
- Awardee
-
University Of Alabama At Birmingham UEI YND4PLMC9AN7
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 2 $3,339,141 obligated
Award facts
- Opportunity
-
- HHSN26818HV00012R Solicitation number
- CARDIA Birmingham Field Center Solicitation Award Notice · Posted Jun 26, 2017
- Combined order value
- $3,339,141 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 51% used
- $6,572,806.00
- Maximum order
- $6,572,806.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- 1 offer Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
- Walsh-Healey Public Contracts Act FAR subpart 22.6
Award details come from SAM.gov/FPDS.
About this IDV
The National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health, awarded a single-award Indefinite Delivery Contract to the University of Alabama at Birmingham (UAB) valued at $6,572,806 with an award date of July 1, 2018, and ultimate completion date of June 30, 2024. The contract provides field center support services in Birmingham, Alabama, for the Coronary Artery Risk Development in Young Adults (CARDIA) study, a longitudinal research program spanning over 30 years. The primary deliverables include continued cohort follow-up and data collection on clinical cardiovascular disease events, facilitation of scientific collaborations among research partners, and limited clinical examinations of CARDIA participants to support ancillary study components. The scientific objectives encompass enhancing statistical power for analyzing predictors of clinical cardiovascular events, studying the progression of risk factors from subclinical to clinical disease states, and identifying novel risk factors and interactions that inform disease pathophysiology. This contract vehicle operates on a cost-no-fee pricing structure with no set-aside designation, reflecting UAB's competitive selection based on established technical capabilities and institutional expertise in cardiovascular research.
Two delivery orders were issued under this IDV, representing task-specific operational phases of the CARDIA field center operations. Task Area A, valued at $2,288,842.69 with a base period from July 1, 2018, to June 30, 2019, and a fourth option extending through June 30, 2023, comprised the foundational field center operations and participant management activities. Task Area B, valued at $1,050,298.53 with performance from November 14, 2019, to October 31, 2021, and a no-cost extension extending ultimate completion to January 31, 2023, addressed supplemental research activities and program continuity during the specified performance window. Both delivery orders maintained cost-no-fee pricing arrangements and were performed at the Birmingham, Alabama facility, supporting UAB's role as the prime contractor in advancing cardiovascular disease research through longitudinal data collection and scientific investigation infrastructure.
Description
The purpose of this acquisition is to provide field center support services in the birmingham, AL area to maximizeuse of data and samples amassed in cardia over more than 30 years to address new questions about thedevelopment and progression of clinical cardiovascular disease and related conditions. The scientific objectivesare to (1) enhancestatistical power to perform analyses of predictors of clinical events; (2) study the progression ofrisk factors tosubclinical to clinical CVD; and (3) identify new risk factors or interactions among factors that informdisease pathophysiology. The operational goals are to (1) conduct continued cohort follow-up and data collection onclinicalevents; (2) continue to foster scientific collaborations; and (3) conduct of a limited clinical examination of thecardia participants as a platform for ancillary study examination components.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Cardia UAB FC - task area B period of performance: 11/14/2019 - 10/31/2021 | National Heart Lung and Blood Institute (NIH) | $1,050,299 | |
| Base - cardia birmingham FC - task area a period of performance: 07/01/2018 - 06/30/2019 | National Heart Lung and Blood Institute (NIH) | $2,288,843 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N92018D00007?
75N92018D00007 was awarded to University Of Alabama At Birmingham by National Heart Lung and Blood Institute (National Institutes of Health) on July 1, 2018.
How much is contract 75N92018D00007 worth?
Orders under 75N92018D00007 have obligated $3,339,141. 75N92018D00007's own ceiling is $6,572,806. A single order can be worth up to $6,572,806.
How many orders have been placed under contract 75N92018D00007?
2 orders have been placed under 75N92018D00007, the latest on November 14, 2019.
Who can order from contract 75N92018D00007?
75N92018D00007 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N92018D00007 competed?
The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV